OAM
PMD

Oxford Asset Management’s Psychemedics Corporation PMD Stock Holding History

Oxford Asset Management’s Portfolio PMD Stock Details PMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,488
Closed -$216K – 1932
2017
Q4 		$216K Sell
10,488
-18,016
-63% -$334K ﹤0.01% 1432
2017
Q3 		$522K Buy
+28,504
New +$627K 0.01% 1181
2017
Q2 		– Sell
-17,700
Closed -$355K – 1741
2017
Q1 		$355K Buy
+17,700
New +$389K 0.01% 1155

Other funds holding PMD

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
MC
Moors & Cabot Boston, Massachusetts $2.34B AUM 30.42% 1-Year Est. Return
TCM
Tieton Capital Management Yakima, Washington $299M AUM 54.55% 1-Year Est. Return
CIC
Crawford Investment Counsel Atlanta, Georgia $5.85B AUM 12.61% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Oxford Asset Management's PMD Position: Q1 2018 in Review

Oxford Asset Management sold out of Psychemedics Corporation (PMD) in Q1 2018, closing a stake of 10,488 shares — an estimated $216K sold.

Oxford Asset Management first reported a position in PMD in Q1 2017 and held it in 3 quarters. The position peaked at $522K in Q3 2017. 50 funds tracked by Wall St. Rank hold PMD as of Q1 2018.

  • Oxford Asset Management reported no remaining Psychemedics Corporation position as of Q1 2018 after selling out during the quarter.
  • Oxford Asset Management sold 10,488 Psychemedics Corporation shares in Q1 2018, an estimated $216K.
  • Oxford Asset Management first reported a position in Psychemedics Corporation in Q1 2017 and held it in 3 quarters.
  • Oxford Asset Management's Psychemedics Corporation position peaked at $522K in Q3 2017.
  • 50 funds tracked by Wall St. Rank held Psychemedics Corporation as of Q1 2018.

Based on Oxford Asset Management's 13F filing for Q1 2018, filed 15 May 2018.